Mimedx (MDXG) Other financing activities (2011 - 2024)
Mimedx's (MDXG) quarterly Other financing activities came in at -$1.2 million in Q4 2024, down 205.18% quarter-over-quarter from $1.1 million in Q1 2024.
Mimedx (MDXG) Other financing activities (2011 - 2024) Analysis & Trends
Mimedx has disclosed Other financing activities across 6 years of filings, most recently posting -$1.2 million for Q4 2024.
- Other financing activities for Q4 2024 came in at -$1.2 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was -$1.2 million (down 205.18% YoY), and the FY2024 annual result was -$57000.0, changed N/A from the prior year.
- Other financing activities came in at -$1.2 million for Q4 2024 at Mimedx, down from $1.1 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $6.5 million in Q3 2020 to a low of -$3.3 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Mimedx | 546.28 Mn | 386.51 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1.16 Mn |
| Dec 31, 2024 | -1.16 Mn |
| Mar 31, 2024 | 1.10 Mn |
| Mar 31, 2024 | 1.10 Mn |
| Dec 31, 2020 | -3.33 Mn |
| Dec 31, 2020 | -3.33 Mn |
| Sep 30, 2020 | 6.54 Mn |
| Sep 30, 2020 | 6.54 Mn |
| Dec 31, 2019 | -6.64 Mn |
| Dec 31, 2019 | -6.64 Mn |
| Sep 30, 2019 | 595,000.00 |
| Sep 30, 2019 | 595,000.00 |
| Dec 31, 2016 | -76,000.00 |
| Dec 31, 2016 | -76,000.00 |
| Sep 30, 2016 | 45,000.00 |
| Sep 30, 2016 | 45,000.00 |
| Jun 30, 2016 | 41,000.00 |
| Jun 30, 2016 | 41,000.00 |
| Mar 31, 2016 | 20,000.00 |
| Mar 31, 2016 | 20,000.00 |